Osteonecrosis maxilar en síndrome antifosfolipídico.  Revisión de la literatura a propósito de un caso

Marco Cedillo Bailón; Fernando Sandoval Vernimmen; Fernando Sandoval Portilla

doi:10.47464/MetroCiencia/vol30/1/2022/128-134

Authors

Marco Cedillo Bailón Universidad San Francisco de Quito https://orcid.org/0000-0002-0110-5731
Fernando Sandoval Vernimmen Universidad San Francisco de Quito https://orcid.org/0000-0002-4345-2408
Fernando Sandoval Portilla Universidad San Francisco de Quito https://orcid.org/0000-0003-0600-0936

DOI:

https://doi.org/10.47464/MetroCiencia/vol30/1/2022/128-134

Keywords:

antiphospholipid syndrome, antiphospholipid antibodies, thrombosis, osteonecrosis, oral surgery

Abstract

Antiphospholipid síndrome (SAF) was first described in 1983 by Hughes and is characterized by being a systemic autoimmune disorder that generates recurrent venous or arterial thrombosis, as well as obstetric morbility due to the persistent production of antiphospholipid antibodies. Thrombophilia can appear in different systems and organs, including bone tissue. This condition can develop especially in patients who accumulate risk factors such as autoimmune diseases, corticosteroid therapy, or exposure to local trauma and chronic infections. In this article, a review of the literature regarding SAF was performed and a case of maxillary osteonecrosis after a dental extraction procedure in a patient with primary SAF is presented. In addition, osteonecrosis is exposed as a possible complication of this disease, for which some treatment alternatives are proposed.

Downloads

Download data is not yet available.

Author Biographies

Marco Cedillo Bailón, Universidad San Francisco de Quito

Universidad San Francisco de Quito, Colegio de Ciencias de la Salud, Escuela de Odontología, Clínica Odontológica, Campus Cumbayá.
Fernando Sandoval Vernimmen, Universidad San Francisco de Quito

Universidad San Francisco de Quito, Colegio de Ciencias de la Salud, Escuela de Odontología, Clínica Odontológica, Campus Cumbayá
Fernando Sandoval Portilla, Universidad San Francisco de Quito

Universidad San Francisco de Quito, Colegio de Ciencias de la Salud, Escuela de Odontología, Clínica Odontológica, Campus Cumbayá

References

Okuyama K, Naruse T, Yutori H, Yanamoto S, Umeda M. Oral surgery in patients with antiphospholipid syndrome. J Oral Sci [Internet]. 2019;61(3):386–90. Available from: https://pubmed.ncbi.nlm.nih.gov/31217370/#:~:text=Oral surgeons should suture oral,of blood coagulation is needed.

Quinteiro L, Talge F, Saraiva S, Moraes B De, Pereira M, Vinícius E, et al. Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome. Thromb Res [Internet]. 2018;171(June):114–20. Available from: https://pubmed.ncbi.nlm.nih.gov/30278301/

Cervera R, Piette J, Font J, Khamashta MA, Shoenfeld Y, Camps T, et al. Antiphospholipid Syndrome Clinical and Immunologic Manifestations and Patterns of Disease Expression in a Cohort of 1000 patients. Am Coll Rheumatol [Internet]. 2002;46(4):1019–27. Available from: https://pubmed.ncbi.nlm.nih.gov/20012628/

Haque W, Kadikoy H, Pacha O, Maliakkal J, Hoang V, Abdellatif A. Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy. Rheumatol Int. 2010;30:719–23.

Firriolo EFJ, Craig S, Rhodus NL, Yepes JF, Sullivan JA, Castellanos AL. Hypercoagulability syndromes : what the dentist needs to know. Oral Surg Oral Med Oral Pathol Oral Radiol. 2007;104(1):3–11.

Rueda JC, Andre M. Osteonecrosis and Antiphospholipid Syndrome. J Clin Rheumatol [Internet]. 2009;15(3):130–2. Available from: https://pubmed.ncbi.nlm.nih.gov/19300287/

Petrosyan V, Milton T, Revington PJ. Hypercoagulopathy and Dento- alveolar Surgery : A Case of Exodontia in a Patient with Hughes ’ Syndrome. Dent Updat Publ [Internet]. 2016;(October):2016–9. Available from: https://doi.org/10.12968/denu.2016.43.8.786

Asherson RA, Cervera R. Microvascular and microangiopathic antiphospholipid-associated syndromes ( “ MAPS ” ) Semantic or antisemantic ? Autoimmun Rev [Internet]. 2008;7:164–7. Available from: https://pubmed.ncbi.nlm.nih.gov/18190872/

Tektonidou MG, Moutsopoulos HM. Osteoarticular Manifestations of Antiphospholipid Syndrome. Rheum Dis Clin North Am [Internet]. 2006;32:523–35. Available from: https://pubmed.ncbi.nlm.nih.gov/16880082/

Gómez-puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S. Antiphospholipid Antibodies Associated with Malignancies : Clinical and Pathological Characteristics of 120 Patients. Semin Arthritis Rheum [Internet]. 2006;35:322–32. Available from: https://pubmed.ncbi.nlm.nih.gov/16616155/

Charles J. Glueck, Robert E. McMahon, Jerry Bouquot, Davis Stroop, Trent Tracy, Ping Wang BR. Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 1996;81(5). Available from: https://www.sciencedirect.com/science/article/abs/pii/S1079210496800473

Gruppo R, Glueck CJ, Mcmahon RE, Bouquot J, Rabinovich BA, Becker ANN, et al. The pathophysiology of alveolar osteonecrosis of the jaw: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J Lab Clin Med [Internet]. 1996;127:481–8. Available from: https://pubmed.ncbi.nlm.nih.gov/8621985/

Miyakis S, Lockshin MD, Atsumi T, Derksen RHWM, Groot PGDE, Koike T. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost [Internet]. 2006;4(November 2005):295–306. Available from: https://pubmed.ncbi.nlm.nih.gov/16420554/

Tektonidou MG, Moutsopoulos HM. Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin North Am [Internet]. 2004;35:259–63. Available from: https://pubmed.ncbi.nlm.nih.gov/15271533/

Marx R. Oral and Maxillofacial Pathology. 2nd editio. Chicago: Quintessenez books; 2012. 87–90 p.